Loading data for ELAB — first visit, this takes a few seconds.

PMGC Inc.

NasdaqCM: ELAB · 即時價格 · USD
0.83
-0.04 (-4.60%)
收盤時: Aug 18, 2026, 3:57 PM

PMGC Inc. (ELAB) Stock Price, Analysis & Data

-4.60%
買價0.61
市值3.77M
營收 (ttm)2.58M
淨利(ttm)-13.57M
貝塔n/a
EPS (ttm)-150.06
本益比(ttm)n/a
正向 PEn/a
P/B (ttm)0.31
P/S (ttm)1.46
Earnings Daten/a
賣價1.09
成交量192,210
20 日平均成交量2,847,680
打開0.87
上一頁關閉0.87
日間範圍0.82 - 0.88
52 週範圍0.82 - 309.89
分析師n/a
目標價n/a
股利n/a
Ex-股利日期n/a

關於ELAB

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss tre...

部門 Healthcare
IPO 日期 Nov 21, 2023
員工 32
證券交易所 NasdaqCM
股票代號 ELAB
完整的公司簡介

財務表現

PMGC 在 2025 年的營收為 590.08K,較前一年的 0 增加 undefined%。 淨利為 -7.75M,較前期增加 24.05%。

財務報表